Skip to main content
. 2019 Feb 8;8(3):972–981. doi: 10.1002/cam4.1977

Table 4.

Univariate analysis of predictors of overall survival

Variable Overall survival (median, mo) HR (95% CI) P‐value
NF1 status
No (sporadic) 57 Ref
Yes 14 2.44 (1.06‐5.60) 0.036
Tumor size
<10 cm 60 Ref
>10 cm 16 3.24 (1.18‐8.88) 0.023
MCD core (%)
Lower tercile 15 Ref
Interm. tercile 28 1.07 (0.40‐2.86) 0.893
Upper tercile 57 0.66 (0.22‐1.98) 0.458
MCD periphery (%)
Lower tercile 30 Ref
Interm. tercile 15 2.54 (0.95‐6.75) 0.062
Upper tercile 60 0.58 (0.19‐1.80) 0.350
MVD core (vessels/mµ2)
Lower tercile 60 Ref
Interm. tercile 36 1.77 (0.60‐5.20) 0.301
Upper tercile 10 2.20 (0.75‐6.42) 0.151
MVD periphery (vessels/mµ2)
Lower tercile 72 Ref
Interm. tercile 36 2.11 (0.57‐7.81) 0.265
Upper tercile 13 8.22 (2.19‐30.81) 0.002
Ki‐67 core (%)
Lower tercile 18 Ref
Interm. tercile 21.5 1.01 (0.33‐3.11) 0.983
Upper tercile 51 0.83 (0.31‐2.23) 0.710
Ki‐67 periphery (%)
Lower tercile 29 Ref
Interm. tercile 57 1.40 (0.45‐4.39) 0.562
Upper tercile 60 2.26 (0.78‐6.56) 0.133

HR, hazard ratio; Interm., intermediate; MCD, mast cell density; MVD, microvascular density; NF1, neurofibromatosis type 1; ref, reference.